KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EPAM Systems (EPAM) Cash & Equivalents (2016 - 2025)

EPAM Systems (EPAM) has disclosed Cash & Equivalents for 16 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 0.76% to $1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 0.76% year-over-year, with the annual reading at $1.3 billion for FY2025, 0.76% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.3 billion at EPAM Systems, up from $1.2 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $2.0 billion in Q3 2024, with the low at $1.0 billion in Q2 2025.
  • Average Cash & Equivalents over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2021.
  • The sharpest move saw Cash & Equivalents surged 49.83% in 2021, then plummeted 41.73% in 2025.
  • Over 5 years, Cash & Equivalents stood at $1.4 billion in 2021, then grew by 16.23% to $1.7 billion in 2022, then rose by 21.11% to $2.0 billion in 2023, then plummeted by 36.83% to $1.3 billion in 2024, then rose by 0.76% to $1.3 billion in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $1.3 billion, $1.2 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.